Compare MNKD & PGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNKD | PGY |
|---|---|---|
| Founded | 1991 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2004 | N/A |
| Metric | MNKD | PGY |
|---|---|---|
| Price | $5.72 | $12.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $10.08 | ★ $35.50 |
| AVG Volume (30 Days) | 4.0M | ★ 5.0M |
| Earning Date | 02-23-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.47 | N/A |
| EPS | 0.10 | ★ 0.93 |
| Revenue | $313,787,000.00 | ★ $1,301,360,000.00 |
| Revenue This Year | $21.29 | $18.57 |
| Revenue Next Year | $25.53 | $14.58 |
| P/E Ratio | $59.56 | ★ $14.71 |
| Revenue Growth | 17.43 | ★ 26.07 |
| 52 Week Low | $3.38 | $8.50 |
| 52 Week High | $6.51 | $44.99 |
| Indicator | MNKD | PGY |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 25.44 |
| Support Level | $5.47 | $13.50 |
| Resistance Level | $6.05 | $15.51 |
| Average True Range (ATR) | 0.31 | 1.34 |
| MACD | 0.00 | -0.73 |
| Stochastic Oscillator | 34.71 | 2.61 |
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Pagaya Technologies Ltd is a financial technology company working to reshape the lending marketplace by using machine learning, data analytics, and sophisticated AI-driven credit and analysis technology. It was built to provide a comprehensive solution to enable the credit industry to deliver customers a positive experience while simultaneously enhancing the broader credit ecosystem. Its proprietary API seamlessly integrates into its next-gen infrastructure network of partners to deliver a premium customer user experience and greater access to credit. The company generates majority of its revenue from United States.